10.04.2015 - We are waiting for a signal to buy shares in Pfizer

Pfizer's share price continues to consolidate between the lower boundary of the rising channel and a strong resistance level at 35.00. In case of breaking through this mark, we expect continued growth with the first targets 36.50 and 37.00. In case of a fall, the signal for the opening of short positions will be fixing the price below 33.70. Our medium-term forecast is positive and we expect a price increase in the near future, but we recommend wait for a signal to open positions.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.